Logo image of CCAP

CRESCENT CAPITAL BDC INC (CCAP) Stock Fundamental Analysis

NASDAQ:CCAP - Nasdaq - US2256551092 - Common Stock - Currency: USD

15.96  +0.07 (+0.44%)

After market: 15.96 0 (0%)

Fundamental Rating

4

Overall CCAP gets a fundamental rating of 4 out of 10. We evaluated CCAP against 231 industry peers in the Capital Markets industry. CCAP has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCAP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCAP was profitable.
In the past year CCAP had a positive cash flow from operations.
In the past 5 years CCAP has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: CCAP reported negative operating cash flow in multiple years.
CCAP Yearly Net Income VS EBIT VS OCF VS FCFCCAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.45%, CCAP is in the better half of the industry, outperforming 63.20% of the companies in the same industry.
CCAP has a Return On Equity of 9.94%. This is comparable to the rest of the industry: CCAP outperforms 54.55% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.43%, CCAP is in line with its industry, outperforming 58.87% of the companies in the same industry.
Industry RankSector Rank
ROA 4.45%
ROE 9.94%
ROIC 4.43%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCAP Yearly ROA, ROE, ROICCCAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 37.32%, CCAP is in the better half of the industry, outperforming 77.92% of the companies in the same industry.
CCAP's Profit Margin has declined in the last couple of years.
CCAP has a better Operating Margin (45.90%) than 82.68% of its industry peers.
In the last couple of years the Operating Margin of CCAP has declined.
CCAP has a Gross Margin (47.51%) which is comparable to the rest of the industry.
CCAP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 45.9%
PM (TTM) 37.32%
GM 47.51%
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
CCAP Yearly Profit, Operating, Gross MarginsCCAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

There is no outstanding debt for CCAP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCAP Yearly Shares OutstandingCCAP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CCAP Yearly Total Debt VS Total AssetsCCAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CCAP has an Altman-Z score of 0.48. This is a bad value and indicates that CCAP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CCAP (0.48) is worse than 65.37% of its industry peers.
CCAP has a debt to FCF ratio of 14.87. This is a negative value and a sign of low solvency as CCAP would need 14.87 years to pay back of all of its debts.
CCAP has a Debt to FCF ratio (14.87) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.18 is on the high side and indicates that CCAP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.18, CCAP perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 14.87
Altman-Z 0.48
ROIC/WACCN/A
WACCN/A
CCAP Yearly LT Debt VS Equity VS FCFCCAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

CCAP has a Current Ratio of 0.29. This is a bad value and indicates that CCAP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCAP has a worse Current ratio (0.29) than 81.39% of its industry peers.
CCAP has a Quick Ratio of 0.29. This is a bad value and indicates that CCAP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCAP's Quick ratio of 0.29 is on the low side compared to the rest of the industry. CCAP is outperformed by 81.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
CCAP Yearly Current Assets VS Current LiabilitesCCAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.43% over the past year.
The Earnings Per Share has been growing slightly by 7.26% on average over the past years.
The Revenue has been growing slightly by 7.19% in the past year.
Measured over the past years, CCAP shows a very strong growth in Revenue. The Revenue has been growing by 29.83% on average per year.
EPS 1Y (TTM)10.43%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-9.84%
Revenue 1Y (TTM)7.19%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-7.12%

3.2 Future

The Earnings Per Share is expected to decrease by -13.17% on average over the next years. This is quite bad
Based on estimates for the next years, CCAP will show a decrease in Revenue. The Revenue will decrease by -6.78% on average per year.
EPS Next Y-18.48%
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%
EPS Next 5YN/A
Revenue Next Year-10.51%
Revenue Next 2Y-6.61%
Revenue Next 3Y-6.78%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCAP Yearly Revenue VS EstimatesCCAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
CCAP Yearly EPS VS EstimatesCCAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.28, the valuation of CCAP can be described as very cheap.
Based on the Price/Earnings ratio, CCAP is valued cheaply inside the industry as 89.61% of the companies are valued more expensively.
CCAP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.12.
A Price/Forward Earnings ratio of 7.71 indicates a rather cheap valuation of CCAP.
Based on the Price/Forward Earnings ratio, CCAP is valued cheaper than 83.98% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.42, CCAP is valued rather cheaply.
Industry RankSector Rank
PE 6.28
Fwd PE 7.71
CCAP Price Earnings VS Forward Price EarningsCCAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

74.89% of the companies in the same industry are more expensive than CCAP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.04
EV/EBITDA N/A
CCAP Per share dataCCAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CCAP's earnings are expected to decrease with -13.17% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.87
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.67%, CCAP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.46, CCAP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, CCAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.67%

5.2 History

CCAP has been paying a dividend for over 5 years, so it has already some track record.
CCAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years4
Div Non Decr Years4
CCAP Yearly Dividends per shareCCAP Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

102.15% of the earnings are spent on dividend by CCAP. This is not a sustainable payout ratio.
DP102.15%
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%
CCAP Yearly Income VS Free CF VS DividendCCAP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M
CCAP Dividend Payout.CCAP Dividend Payout, showing the Payout Ratio.CCAP Dividend Payout.PayoutRetained Earnings

CRESCENT CAPITAL BDC INC

NASDAQ:CCAP (5/8/2025, 4:30:02 PM)

After market: 15.96 0 (0%)

15.96

+0.07 (+0.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-14 2025-05-14
Inst Owners47.93%
Inst Owner Change-0.3%
Ins Owners1.09%
Ins Owner Change0%
Market Cap591.48M
Analysts85
Price Target19.47 (21.99%)
Short Float %0.71%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield 10.67%
Yearly Dividend1.9
Dividend Growth(5Y)N/A
DP102.15%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-29 2025-08-29 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.59%
Min EPS beat(2)-4.28%
Max EPS beat(2)9.46%
EPS beat(4)2
Avg EPS beat(4)7.42%
Min EPS beat(4)-4.28%
Max EPS beat(4)24.72%
EPS beat(8)6
Avg EPS beat(8)6.07%
EPS beat(12)8
Avg EPS beat(12)4.28%
EPS beat(16)11
Avg EPS beat(16)4.74%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-3.76%
Max Revenue beat(2)3.96%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-3.76%
Max Revenue beat(4)3.96%
Revenue beat(8)6
Avg Revenue beat(8)1.35%
Revenue beat(12)7
Avg Revenue beat(12)1.11%
Revenue beat(16)9
Avg Revenue beat(16)1.45%
PT rev (1m)-1.27%
PT rev (3m)-1.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 6.28
Fwd PE 7.71
P/S 3
P/FCF 10.04
P/OCF 10.04
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)2.54
EY15.91%
EPS(NY)2.07
Fwd EY12.97%
FCF(TTM)1.59
FCFY9.96%
OCF(TTM)1.59
OCFY9.96%
SpS5.33
BVpS19.98
TBVpS19.98
PEG (NY)N/A
PEG (5Y)0.87
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 9.94%
ROCE 5.6%
ROIC 4.43%
ROICexc 4.45%
ROICexgc 4.47%
OM 45.9%
PM (TTM) 37.32%
GM 47.51%
FCFM 29.85%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 14.87
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.5
Cash Conversion N/A
Profit Quality 79.98%
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z 0.48
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)123.47%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.43%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-9.84%
EPS Next Y-18.48%
EPS Next 2Y-12.85%
EPS Next 3Y-13.17%
EPS Next 5YN/A
Revenue 1Y (TTM)7.19%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-7.12%
Revenue Next Year-10.51%
Revenue Next 2Y-6.61%
Revenue Next 3Y-6.78%
Revenue Next 5YN/A
EBIT growth 1Y8.05%
EBIT growth 3Y21.99%
EBIT growth 5Y23.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.18%
OCF growth 3YN/A
OCF growth 5YN/A